The anti-tumor activities of AGN and decursin were shown to be associated with inhibition of multiple survival signaling pathways, such as PI3K/AKT, ERK33, NF-κB34, and Wnt/β-catenin35. This evidence concerns the gene AKT1 and neoplasm.